SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-18-008440
Filing Date
2018-06-11
Accepted
2018-06-11 09:54:08
Documents
4
Period of Report
2018-06-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44843
2 ex10-1.htm EX-10.1 220437
3 ex10-2.htm EX-10.2 46615
4 ex99-1.htm EX-99.1 15032
  Complete submission text file 0001493152-18-008440.txt   328262
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54933 | Film No.: 18891136
SIC: 2834 Pharmaceutical Preparations